Skip to content
ASBESTOSIS CANCER CENTER

Asbestosis Cancer Center

asbestosiscancer.center

Menu
  • asbestosiscancer news
  • Treatment
  • Asbestosis Treatmeant
  • Tipes of Cancer
  • About us
    • Terms and Conditions
    • DMCA
    • Contact
    • Privacy Policy
    • DMCA
Menu

NHS England » NHS seeks views on proposed new standards for cancer – NHS England

Posted on April 6, 2022 by Asbestosis Cancer Center

We’ve put some small files called cookies on your device to make our site work.
We’d also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We’ll use a cookie to save your choice. You can read more about our cookies before you choose.
 

Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.
You can use the filters to show only news items that match your interests
The NHS is today launching a consultation on proposed new standards that will help diagnose more cancers earlier and save more lives.
Developed with clinical leaders, the proposals – supported by NHS staff as well as patient groups and cancer charities – aim to simplify and update cancer standards, based on the recommendations of the Independent Cancer Taskforce.
Patients, clinicians and the public will be asked to share their views on the proposed standards over the next month, with a report setting out the changes published today.
Cancer currently has a complex set of nine separate performance standards, with different targets covering different routes into the system, for example, screening or a GP referral.
The new plan proposes ensuring patients have the same opportunity for faster diagnosis and treatment, including:
These new standards aim to make diagnosis and treatment timelines easier to understand for people with suspected cancer and their families, while also helping to diagnose cancers earlier and save more lives.
Before the faster diagnosis standard was introduced, access standards for cancer have remained unchanged since 2009. The current two week wait target sets no expectation of when patients should receive test results or actually get a confirmed diagnosis.
Cancer care has been prioritised throughout the pandemic with latest data showing the number of people getting checked for cancer increased by over half a million (512,110) in one year between December 2020 and December 2021.
In December alone, there were over 215,000 urgent referrals for cancer and more than nine out of 10 people started treatment within one month.
Dame Cally Palmer, NHS National Director for Cancer said: “Access standards have been key to improving timeliness of treatment for people with cancer since they were first introduced in 2000.
“As we see advances in diagnosis and treatments for cancer, it is only right that these standards are modernised – so that we can ensure patients are diagnosed more quickly and are given the treatment they need as soon as possible, helping us save even more lives.
“These proposed changes are an important part of improving cancer care and so from today, the NHS will be inviting views from patients, staff and the public”.
Professor Peter Johnson, National Clinical Director for Cancer for NHS England, said: “We know that people having tests for possible cancer want to know the results quickly, and updating the standards to reflect this will help us to make sure we are able to deliver the best possible care.
“We are encouraging colleagues in NHS cancer services to share their views on the consultation to ensure we have standards that are better for people with cancer”.
Health and Social Care Secretary, Sajid Javid said: “As part of our 10-Year Cancer Plan, we want to offer patients the best possible care and treatment.
“These proposals will help us speed up diagnosis times and treatment, and save more lives.
“The NHS wants to hear from as many people as possible – and is seeking advice from patients, staff and the public. Please, make your voices heard”.
Under the new proposals, the NHS would focus on the time from referral to people finding out their results within a maximum of 28 days. This faster diagnosis standard has a clearer focus on measuring and incentivising early diagnosis, rather than just time to first be seen.
Areas where the new standards have been tested have shown that performance against the 62-day referral to treatment standard was significantly higher (74.9%) than the control group (71.7%) when using the new measures.
Proposals are in addition to the target announced in the elective recovery plan, published last month, which outlined the NHS aim to return the number of people waiting more than 62 days from an urgent referral back to pre-pandemic levels by March 2023.
Catherine Harper-Wynne, Chair of the Breast Cancer Faster Diagnosis Group, said: “The proposed update in standards provides a better reflection of our current clinical approach and allows for greater flexibility to offer patients the most efficient route to diagnosis, allowing us to start treatment as quickly as possible. For breast cancer patients, there is evidence, from the pilot already completed, that a higher proportion of patients had cancer ruled out within 28 days”.
Jane Lyons, CEO of charity Cancer52, said: “People with rare and less common cancers often have vague symptoms and it can take longer for their cancer to be diagnosed. So a commitment to a diagnosis in 28 days for all cancers, including those that are more challenging to diagnose, is a good step forward. Earlier diagnosis can mean more people start treatment sooner and more lives will be saved, and we support work to help the NHS meet its ambitions to diagnose more cancers faster and earlier”.
Patients have told the NHS that the focus on achieving a rapid diagnosis or ruling out of cancer is the right one, and is more meaningful to patients than the timing of a first appointment.
Anyone wishing to submit their views to the consultation can do so on our website or by email to england.reviewofstandards@nhs.net.

See also  Foundation Honors Memory of Young Cancer Patient at Monmouth Medical Center with a Special 'Living Room' for Teenagers - RWJBarnabas Health

source

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • artnet : Sotheby’s Sold a Jean Prouv Table for $1.6 Million Last Month—But Didn’t Mention It Might Contain Asbestos
  • Don’t Follow This Tip From Julia Child’s 1970s Bread Recipe!
  • Sotheby’s Sold a Jean Prouvé Table for $1.6 Million Last Month—But Didn’t Mention It Might Contain Asbestos
  • On Asbestos LRB 21 July 2022
  • Asbestos health war: FS residents running out of patience

Recent Comments

  1. selection of modern and classic books waiting to be discovered. All free and available in most ereader formats. download free books https://www.skylineuniversity.ac.ae/advisory-council on Stem cells could help prevent diabetes onset from cancer immunotherapy – New Atlas
  2. selection of modern and classic books waiting to be discovered. All free and available in most ereader formats. download free books https://www.skylineuniversity.ac.ae/advisory-council on Particles released by red blood cells are effective carriers for anti-cancer immunotherapy – Science Daily
  3. selection of modern and classic books waiting to be discovered. All free and available in most ereader formats. download free books https://www.skylineuniversity.ac.ae/advisory-council on Dairy products linked to increased risk of cancer – Medical Xpress
  4. selection of modern and classic books waiting to be discovered. All free and available in most ereader formats. download free books https://www.skylineuniversity.ac.ae/advisory-council on The nanodrug that attacks cancer twice: Novel RNA technology: Boosting personalized cancer care – Science Daily
  5. selection of modern and classic books waiting to be discovered. All free and available in most ereader formats. download free books https://www.skylineuniversity.ac.ae/advisory-council on Immune System Attacks Itself in a Rare Type of Blood Cancer – Technology Networks
  • artnet : Sotheby’s Sold a Jean Prouv Table for $1.6 Million Last Month—But Didn’t Mention It Might Contain Asbestos
  • Don’t Follow This Tip From Julia Child’s 1970s Bread Recipe!
  • Sotheby’s Sold a Jean Prouvé Table for $1.6 Million Last Month—But Didn’t Mention It Might Contain Asbestos
  • On Asbestos LRB 21 July 2022
  • Asbestos health war: FS residents running out of patience
  • Asbestosis Treatmeant
  • asbestosiscancer news
  • Tipes of Cancer
  • Treatment

Info

  • Aviso Legal
  • Contact
  • Personalizar Cookies
  • Política de Cookies
  • Política de Privacidad
  • DMCA
  • Terms and Conditions
  • artnet : Sotheby’s Sold a Jean Prouv Table for $1.6 Million Last Month—But Didn’t Mention It Might Contain Asbestos
  • Don’t Follow This Tip From Julia Child’s 1970s Bread Recipe!
  • Sotheby’s Sold a Jean Prouvé Table for $1.6 Million Last Month—But Didn’t Mention It Might Contain Asbestos
  • On Asbestos LRB 21 July 2022
  • Asbestos health war: FS residents running out of patience

Blue AsbestosisASBESTOSIS CANCER CENTER

➡️ Blue Asbestosis an asbestos company is exposed for selling toxic products to the public. This company specifically targeted people who could not afford to buy their products, which led to the installation of this asbestos in homes and other buildings across America. The result was an epidemic of blue asbestos related diseases that killed thousand

  • asbestosiscancer news
  • Treatment
  • Asbestosis Treatmeant
  • Tipes of Cancer
  • About us
    • Terms and Conditions
    • DMCA
    • Contact
    • Privacy Policy
    • DMCA
©2022 Asbestosis Cancer Center | Built using WordPress and Responsive Blogily theme by Superb
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT